Jean-Marc Taymans
Affiliations: | 2014- | INSERM, Lille, France |
Google:
"Jean-Marc Taymans"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Marie-Christine CHARTIER-HARLIN | research scientist | 2014- | INSERM, Lille, France |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Naaldijk Y, Fernández B, Fasiczka R, et al. (2024) A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells. Npj Parkinson's Disease. 10: 12 |
| Iannotta L, Emanuele M, Favetta G, et al. (2023) PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation. Frontiers in Molecular Neuroscience. 16: 1269387 |
| Taymans JM, Fell M, Greenamyre T, et al. (2023) Perspective on the current state of the LRRK2 field. Npj Parkinson's Disease. 9: 104 |
| Filippini F, Nola S, Zahraoui A, et al. (2023) Secretion of VGF relies on the interplay between LRRK2 and post-Golgi v-SNAREs. Cell Reports. 42: 112221 |
| Taymans JM, Mutez E, Sibran W, et al. (2023) Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkers. Npj Parkinson's Disease. 9: 21 |
| Coku I, Mutez E, Eddarkaoui S, et al. (2022) Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Marchand A, Sarchione A, Athanasopoulos PS, et al. (2022) A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively. Cells. 11 |
| Cogo S, Ho FY, Tosoni E, et al. (2022) The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation. Brain Research. 147781 |
| Sarchione A, Marchand A, Taymans JM, et al. (2021) Alpha-Synuclein and Lipids: The Elephant in the Room? Cells. 10 |
| Cresto N, Gardier C, Gaillard MC, et al. (2021) The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo. International Journal of Molecular Sciences. 22 |